Samsung has officially opened up the One UI 8.5 beta program in multiple countries. The update brings significant changes and new features to the Galaxy S25 series. Samsung is expected to expand the ...

Collier Jennings is an entertainment journalist with a substantial amount of experience under his belt. Collier, or "CJ" to his friends and family, is a dedicated fan of genre films - particularly ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Kaulig Racing will not compete in the NASCAR Xfinity Series next season nor for the foreseeable future, as confirmed on Wednesday morning by team president Chris Rice. Rice spoke at length about the ...

Netflix just announced its November 2025 lineup, but it omitted a major title that is heading to Netflix globally this November: the complete four-season run of the Golden Globe-winning Showtime ...

Investment keeps flowing to humanoid robotics companies. Figure AI Inc. today announced that, with its Series C funding round, it has surpassed $1 billion in committed capital, bringing its post-money ...

Smartphone startup Nothing announced today that it closed its Series C round of $200 million, which was led by the investment firm Tiger Global. With this round, the consumer electronics company is ...

WASHINGTON, September 9, 2025 — The World Bank’s Board of Executive Directors today approved a new program to support coastal communities in India by protecting and conserving ecosystems, reducing ...

Ambient AI platform Ambience Healthcare banked $243 million in series C funding, marking one of the largest health tech raises so far in 2025. The funding boosts the company's valuation to $1.25 ...

The five-year-old company views artificial intelligence and robotics as necessary to automate defense component manufacturing and make it happen at scale. Hadrian, a startup that leans on automation ...

Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.